Global Anti-Obesity Drugs Market Trends and Drivers, Restraints, and Opportunities 2017-2023 - Product Thumbnail Image

Global Anti-Obesity Drugs Market Trends and Drivers, Restraints, and Opportunities 2017-2023

  • Report
  • 71 Pages
From
Global Diabetes and Obesity Drugs Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Diabetes and Obesity Drugs Market Analysis 2016 - Forecast to 2022

  • Report
  • 141 Pages
From
Obesity Drugs and Therapies: Technologies and Global Markets - Product Thumbnail Image

Obesity Drugs and Therapies: Technologies and Global Markets

  • Report
From
Anti-Obesity Prescription Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 - Product Thumbnail Image

Anti-Obesity Prescription Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • Report
  • 100 Pages
From
Contrave 2016 U.S Promotional Report - Product Thumbnail Image

Contrave 2016 U.S Promotional Report

  • Report
  • 24 Pages
From
Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • 135 Pages
From
CNS Cluster Addiction Drug Development Pipeline Review, 2017 - Product Thumbnail Image

CNS Cluster Addiction Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Global Anti-Obesity Drugs Market - Growth, Trends & Forecast 2017 - 2022 - Product Thumbnail Image

Global Anti-Obesity Drugs Market - Growth, Trends & Forecast 2017 - 2022

  • Report
  • 205 Pages
From
Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022 - Product Thumbnail Image

Global Controlled Drug Delivery Market & Clinical Trial Outlook 2022

  • Report
  • 870 Pages
From
Obesity - Pipeline Review, H2 2017 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2017

  • Report
  • 518 Pages
From
Neuropathic Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2017

  • Report
  • 488 Pages
From
U.S. Markets for Obesity Drugs & Devices - Product Thumbnail Image

U.S. Markets for Obesity Drugs & Devices

  • Report
  • 176 Pages
From
Oral Proteins and Peptides Market (3rd Edition), 2018-2030 - Product Thumbnail Image

Oral Proteins and Peptides Market (3rd Edition), 2018-2030

  • Report
  • 421 Pages
From
Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017-2030 - Product Thumbnail Image

Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017-2030

  • Report
  • 443 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 344 Pages
From
Orexigen's Contrave: Phase II data show promising efficacy; safety still needs broader check - Product Thumbnail Image

Orexigen's Contrave: Phase II data show promising efficacy; safety still needs broader check

  • Report
  • 29 Pages
From
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1600 Pages
From
Drug Addiction - Pipeline Review, H2 2018 - Product Thumbnail Image

Drug Addiction - Pipeline Review, H2 2018

  • Report
  • 171 Pages
From
Opioid Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Opioid Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Pipeline Review, H1 2018

  • Report
  • 56 Pages
From
Loading Indicator
adroll